Kiran Devisetty, MD, Joseph K. Salama, MD Journal of Thoracic Oncology

Slides:

Advertisements

Similar presentations

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages

Advertisements

Management of independent motion between multiple targets in lung cancer radiation therapy Feng Liu, PhD, An Tai, PhD, Ergun Ahunbay, PhD, Elizabeth.

Neoplastic Fever Caused by Lung Cancer

Kazuma Nagata, MD, Reiko Kaji, MD, Keisuke Tomii, MD

Detection of regional radiation-induced lung injury using hyperpolarized 129Xe chemical shift imaging in a rat model involving partial lung irradiation:

Jeffrey Bradley, MD Journal of Thoracic Oncology

Marked Tumor Response and Fatal Hemoptysis During Radiation for Lung Cancer in a Human Immunodeficiency Virus-Positive Patient Taking Nelfinavir Christopher.

Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease Eisaku.

Acute and Progressive Tracheal Stenosis after Proton Beam Therapy with Concurrent Chemotherapy for Non–Small Cell Lung Cancer Yoshitaka Zenke, MD, Shigeki.

Abscopal Effect of Nivolumab in a Patient with Primary Lung Cancer

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

Disparities in Treatment of Patients with Inoperable Stage I Non–Small Cell Lung Cancer: A Population-Based Analysis Matthew Koshy, MD, Renuka Malik,

Radiotherapeutic Management of Non–Small Cell Lung Cancer in the Minimal Resource Setting Danielle Rodin, MD, Surbhi Grover, MD, MPH, Melody J. Xu, MD,

Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D

Severe Local Toxicity after Lung Stereotactic Body Radiation Therapy: Lesional Abscess Leading to Bronchocutaneous Fistula Requiring Surgical Marsupialization

Postoperative Proton Therapy in the Management of Stage III Thymoma

Radiotherapy Rescue of a Nivolumab-Refractory Immune Response in a Patient with PD-L1–Negative Metastatic Squamous Cell Carcinoma of the Lung Zhigang.

Stereotactic Radiotherapy for Pulmonary Oligometastases: A Systematic Review Shankar Siva, MBBS, Michael MacManus, MD, MRCP, FRCR, FRANZCR, David Ball,

Acute and Progressive Tracheal Stenosis after Proton Beam Therapy with Concurrent Chemotherapy for Non–Small Cell Lung Cancer Yoshitaka Zenke, MD, Shigeki.

Electronic Updates for JTO Readers

The Moth-Eaten Lung Journal of Thoracic Oncology

Tracheoesophageal Fistula Associated with Bevacizumab 21 Months after Completion of Radiation Therapy Elizabeth Gore, MD, Adam Currey, MD, Nicholas Choong,

Half-Body Irradiation With Tomotherapy for Pain Palliation in Metastatic Breast Cancer Carlo Furlan, MD, Marco Trovo, MD, Annalisa Drigo, ScD, MPh, Elvira.

Frank Detterbeck, MD Journal of Thoracic Oncology

Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non–Small-Cell.

Neoplastic Fever Caused by Lung Cancer

Successful Treatment with Erlotinib after Gefitinib-Induced Severe Interstitial Lung Disease Masayuki Takeda, MD, PhD, Isamu Okamoto, MD, PhD, Chihiro.

A Severe Photosensitivity Dermatitis Caused by Crizotinib

Follow-Up of Patients after Stereotactic Radiation for Lung Cancer: A Primer for the Nonradiation Oncologist Kitty Huang, MSc, MDCM, David A. Palma,

Vertebral Collapse Caused by Bone Metastasis

Toxicities of Organs at Risk in the Mediastinal and Hilar Regions Following Stereotactic Body Radiotherapy for Centrally Located Lung Tumors Shuichi.

Effective Treatment with Icotinib in Primary Adenoid Cystic Carcinoma of the Lung with Liver Metastasis Zhengbo Song, MD, Wei Wu, MD, Yiping Zhang, MD

Technical Advances of Radiation Therapy for Thymic Malignancies

Jeffrey Bradley, MD, Issam El Naqa, PhD Journal of Thoracic Oncology

ITV-Based Robust Optimization for VMAT Planning of Stereotactic Body Radiation Therapy of Lung Cancer Xiaoying Liang, PhD, Dandan Zheng, PhD, Maria Mamalui-Hunter,

Disease Flare After Treatment Discontinuation in a Patient With EML4-ALK Lung Cancer and Acquired Resistance to Crizotinib Oana Pop, MD, Augustin Pirvu,

Massive Bronchogenic Cyst

“The Best-Laid Plans … Often go Awry …”

Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response

Elizabeth Cathcart-Rake, MD, Ariel Lopez-Chavez, MD, MS

Appropriateness of Surgical Approach in Black Patients with Lung Cancer—15 Years Later, Little Has Changed Emanuela Taioli, MD, PhD, Raja Flores, MD

Osteoblastic Bone Lesions Developing During Treatment with Erlotinib Indicate Major Response in Patients with Non-small Cell Lung Cancer: A Brief Report

Stereotactic Body Radiotherapy in Patients with Previous Pneumonectomy: Safety and Efficacy Robert Thompson, MD, Meredith Giuliani, MBBS, Mei Ling Yap,

Proton SBRT for Medically Inoperable Stage I NSCLC

Khaled Adil, MD, Marija Popovic, PhD, Fabio L. Cury, MD, Sergio L

Stereotactic Body Radiation Therapy for Primary Lung Cancers >3 Centimeters John J. Cuaron, MD, Ellen D. Yorke, PhD, Amanda Foster, BA, Meier Hsu, MS,

A Case of Nontuberculous Mycobacteria Highly Suspected as Lung Cancer Invading the Aortic Arch Tadashi Umehara, MD, Masaya Aoki, MD, PhD, Aya Harada,

Nicholas Trakul, MD, PhD, Jeremy P

Jeffrey Bradley, MD Journal of Thoracic Oncology

Iris Metastasis from Small-Cell Lung Cancer

Patterns of Local and Nodal Failure in Malignant Pleural Mesothelioma After Extrapleural Pneumonectomy and Photon-Electron Radiotherapy Vishal Gupta,

Nicholas W. Choong, MD, Robert S. Hellman, MD

T4 or MI? Journal of Thoracic Oncology Volume 6, Issue 3, (March 2011)

Stereotactic Body Radiation Therapy for the Treatment of Primary Cardiac Angiosarcoma Causing Hemodynamic Instability Prashant Gabani, MD, Benjamin W.

Cone beam CT based dose calculation in the thorax region

Gaurav Marwaha, MD, Kevin L. Stephans, MD, Neil M

Giant Desmoid Tumor of the Chest Wall

Antiangiogenesis Induced Tumor Cavitation in Lung Cancer

Pulmonary Atelectasis after Stereotactic Ablative Radiotherapy for a Central Lung Tumor Sashendra Senthi, MBChB, FRANZCR, Eric F Ullmann, MD, Suresh.

International Thymic Malignancies Interest Group: A Way Forward

Tetsuzo Tagawa, MD, Miyuki Takasu, MD, Teruyoshi Ishida, MD

Intrathoracic Desmoid Tumor: Brief Report and Review of Literature

Todd J. Carpenter, MD, Kenneth E. Rosenzweig, MD

In pregnancy, aortic tissue is the issue

Formation of a Bronchoesophageal Fistula Following Concurrent Radiation and Chemotherapy for Lung Cancer in the Setting of Behçet's Disease Jeffrey Meyer,

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

Patterns-of-Care for Thoracic Stereotactic Body Radiotherapy among Practicing Radiation Oncologists in the United States Megan E. Daly, MD, Julian R.

Stereotactic Body Radiotherapy for Central Lung Tumors

A Review of First-Line Treatment for Small-cell Lung Cancer

Dose-Escalated Stereotactic Body Radiotherapy (SBRT) as a Salvage Treatment for Two Cases with Relapsed Peripheral Lung Cancer After Initial SBRT Shuichi.

Presentation transcript:

Tumor Necrosis and Cavitation after Stereotactic Body Radiation Therapy Kiran Devisetty, MD, Joseph K. Salama, MD Journal of Thoracic Oncology Volume 5, Issue 7, Pages 1100-1102 (July 2010) DOI: 10.1097/JTO.0b013e3181d899d7 Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 Radiation isodose distribution in coronal, axial, and sagittal planes for patient 1 (A, February 2, 2009) and patient 2 (B, March 23, 2009). Volume of tissue receiving 50% (2700 cGy, light blue), 95% (5130 cGy, dark blue), 100% (5400 cGy, red), 105% (5670 cGy, orange), 110% (5940, yellow), and 120% (6480 cGy, white) of total radiation dose are displayed. Journal of Thoracic Oncology 2010 5, 1100-1102DOI: (10.1097/JTO.0b013e3181d899d7) Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 2 Cone beam computed tomography (CT) scans before the third and final dose of radiation in coronal, axial, and sagittal planes for patient 1 (A, February 9, 2009) and patient 2 (B, March 30, 2009). Both patients demonstrated rapid and significant central cavitation of their tumors when compared with the second treatment cone beam CT that was just 3 days prior. Journal of Thoracic Oncology 2010 5, 1100-1102DOI: (10.1097/JTO.0b013e3181d899d7) Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions